NANORAY-312: A phase III pivotal study of NBTXR3 activated by investigator’s choice of radiotherapy alone or radiotherapy in combination with cetuximab for platinum-based chemotherapy-ineligible elderly patients with locally advanced head and neck squamous cell carcinoma.

Authors

null

Christophe Le Tourneau

Institut Curie, Paris, France

Christophe Le Tourneau , Caroline Hoffmann , Zoltan Takacsi-Nagy , Xavier Liem , Sébastien Salas , Anais Debard , Laetitia Finzi , Leonard A Farber , Miranda Gogishvili , Giorgi Kristesashvili , Tamta Makharadze , Sue S. Yom

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT04892173

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS6110)

DOI

10.1200/JCO.2022.40.16_suppl.TPS6110

Abstract #

TPS6110

Poster Bd #

95a

Abstract Disclosures

Similar Posters

First Author: Victoria Meucci Villaflor

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Toxicities and outcomes of neoadjuvant treatment in elderly patients with locally advanced rectal cancer: A scoping review.

Toxicities and outcomes of neoadjuvant treatment in elderly patients with locally advanced rectal cancer: A scoping review.

First Author: Ruba Ahmed Mohammed Hamed

First Author: Christophe Le Tourneau